TGF-β 信号转导及抑制性 Smads 在非小细胞肺癌中的作用。
TGF-beta signaling and the role of inhibitory Smads in non-small cell lung cancer.
机构信息
Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
出版信息
J Thorac Oncol. 2010 Apr;5(4):417-9. doi: 10.1097/JTO.0b013e3181ce3afd.
Abstract
The signaling pathway mediated by transforming growth factor-beta (TGF-beta) participates in various biologic processes, including cell growth, differentiation, angiogenesis, apoptosis, and extracellular matrix remodeling. In the context of cancer, TGF-beta signaling can inhibit tumor growth in early-stage tumors. However, in late-stage tumors, the very same pathway promotes tumor invasiveness and metastasis. This paradoxical effect is mediated through similar to mothers against decapentaplegic or Smad protein dependent and independent mechanisms and provides an opportunity for targeted cancer therapy. This review summarizes the molecular process of TGF-beta signaling and the changes in inhibitory Smads that contribute to lung cancer progression. We also present current approaches for rational therapies that target the TGF-beta signaling pathway in cancer.
摘要
转化生长因子-β（TGF-β）介导的信号通路参与多种生物学过程，包括细胞生长、分化、血管生成、凋亡和细胞外基质重塑。在癌症的背景下，TGF-β信号通路可以抑制早期肿瘤的生长。然而，在晚期肿瘤中，同样的通路促进肿瘤的侵袭和转移。这种矛盾的效应是通过类似母亲抗 decapentaplegic 或 Smad 蛋白依赖和非依赖的机制介导的，为靶向癌症治疗提供了机会。本文总结了 TGF-β信号通路的分子过程以及抑制性 Smad 蛋白的变化在促进肺癌进展中的作用。我们还介绍了目前针对癌症中 TGF-β信号通路的合理治疗方法。
相似文献
1
TGF-beta signaling and the role of inhibitory Smads in non-small cell lung cancer.TGF-β 信号转导及抑制性 Smads 在非小细胞肺癌中的作用。
J Thorac Oncol. 2010 Apr;5(4):417-9. doi: 10.1097/JTO.0b013e3181ce3afd.
2
Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.SOX2对TIF1γ的抑制促进了非小细胞肺癌中转化生长因子-β诱导的上皮-间质转化。
Oncogene. 2016 Feb 18;35(7):867-77. doi: 10.1038/onc.2015.141. Epub 2015 May 11.
3
Role of TGF-β signaling in curcumin-mediated inhibition of tumorigenicity of human lung cancer cells.TGF-β 信号通路在姜黄素抑制人肺癌细胞致瘤性中的作用。
J Cancer Res Clin Oncol. 2013 Apr;139(4):563-72. doi: 10.1007/s00432-012-1352-6. Epub 2012 Nov 16.
4
RNF111/Arkadia is regulated by DNA methylation and affects TGF-β/Smad signaling associated invasion in NSCLC cells.RNF111/Arkadia 受 DNA 甲基化调控，并影响 NSCLC 细胞中 TGF-β/Smad 信号相关的侵袭。
Lung Cancer. 2015 Oct;90(1):32-40. doi: 10.1016/j.lungcan.2015.07.010. Epub 2015 Jul 26.
5
Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.TGF-β 信号通路阻断对人 A549 肺腺癌细胞系的影响。
Mol Med Rep. 2011 Sep-Oct;4(5):1007-15. doi: 10.3892/mmr.2011.530. Epub 2011 Jul 1.
6
Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis.转化生长因子-β1及其受体在人肺癌和小鼠肺癌发生中的作用
Exp Lung Res. 2000 Dec;26(8):685-707. doi: 10.1080/01902140150216765.
7
CCT6A suppresses SMAD2 and promotes prometastatic TGF-β signaling.CCT6A抑制SMAD2并促进促转移的TGF-β信号传导。
J Clin Invest. 2017 May 1;127(5):1725-1740. doi: 10.1172/JCI90439. Epub 2017 Apr 4.
8
Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.中药补肺汤通过在体内外抑制转化生长因子β1信号通路减轻非小细胞肺癌的上皮-间质转化
J Ethnopharmacol. 2017 May 23;204:45-57. doi: 10.1016/j.jep.2017.04.008. Epub 2017 Apr 12.
9
Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.Smad7蛋白与受体调节型Smads（R-Smads）相互作用，以抑制转化生长因子-β（TGF-β）/Smad信号传导。
J Biol Chem. 2016 Jan 1;291(1):382-92. doi: 10.1074/jbc.M115.694281. Epub 2015 Nov 10.
10
Ski prevents TGF-β-induced EMT and cell invasion by repressing SMAD-dependent signaling in non-small cell lung cancer.Ski通过抑制非小细胞肺癌中SMAD依赖性信号传导来阻止TGF-β诱导的上皮-间质转化和细胞侵袭。
Oncol Rep. 2015 Jul;34(1):87-94. doi: 10.3892/or.2015.3961. Epub 2015 May 7.
引用本文的文献
1
Recent advances in therapeutic use of transforming growth factor-beta inhibitors in cancer and fibrosis.转化生长因子-β抑制剂在癌症和纤维化治疗应用中的最新进展。
Front Oncol. 2025 Apr 25;15:1489701. doi: 10.3389/fonc.2025.1489701. eCollection 2025.
2
Comprehensive multimodal and multiomic profiling reveals epigenetic and transcriptional reprogramming in lung tumors.综合多模态和多组学分析揭示了肺肿瘤中的表观遗传和转录重编程。
Commun Biol. 2025 Mar 31;8(1):527. doi: 10.1038/s42003-025-07954-8.
3
Exploring the Role of the TGF-β Signaling Pathway in Colorectal Precancerous Polyps Biochemical Genetics.探索转化生长因子-β信号通路在结直肠癌前息肉生化遗传学中的作用。
Biochem Genet. 2025 Apr;63(2):1116-1148. doi: 10.1007/s10528-024-10988-y. Epub 2024 Dec 5.
4
Overcoming EGFR-TKI resistance by targeting the tumor microenvironment.通过靶向肿瘤微环境克服表皮生长因子受体酪氨酸激酶抑制剂（EGFR-TKI）耐药性
Chin Med J Pulm Crit Care Med. 2024 Sep 16;2(3):151-161. doi: 10.1016/j.pccm.2024.08.002. eCollection 2024 Sep.
5
Therapeutic targeting of TGF-β in lung cancer.肺癌中转化生长因子-β的治疗靶向作用
FEBS J. 2025 Apr;292(7):1520-1557. doi: 10.1111/febs.17234. Epub 2024 Jul 31.
6
Cholesterol and Immune Microenvironment: Path Towards Tumorigenesis.胆固醇与免疫微环境：肿瘤发生之路。
Curr Nutr Rep. 2024 Sep;13(3):557-565. doi: 10.1007/s13668-024-00542-y. Epub 2024 May 2.
7
Paracrine Regulation and Immune System Pathways in the Inflammatory Tumor Microenvironment of Lung Cancer: Insights into Oncogenesis and Immunotherapeutic Strategies.肺癌炎性肿瘤微环境中的旁分泌调节与免疫系统通路：对肿瘤发生及免疫治疗策略的见解
Cancers (Basel). 2024 Mar 10;16(6):1113. doi: 10.3390/cancers16061113.
8
TGF-β as Predictive Marker and Pharmacological Target in Lung Cancer Approach.转化生长因子-β作为肺癌治疗中的预测标志物和药理学靶点
Cancers (Basel). 2023 Apr 14;15(8):2295. doi: 10.3390/cancers15082295.
9
Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway.超级增强子劫持 LINC01977 促进依赖经典 TGF-β/SMAD3 通路的早期肺腺癌恶性转化。
J Hematol Oncol. 2022 Aug 18;15(1):114. doi: 10.1186/s13045-022-01331-2.
10
Salvianolic acid B acts against non‑small cell lung cancer A549 cells via inactivation of the MAPK and Smad2/3 signaling pathways.丹酚酸 B 通过抑制 MAPK 和 Smad2/3 信号通路对非小细胞肺癌 A549 细胞起作用。
Mol Med Rep. 2022 May;25(5). doi: 10.3892/mmr.2022.12700. Epub 2022 Mar 29.
本文引用的文献
1
Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.转化生长因子β1（TGFβ1）基因rs1982073处的单核苷酸多态性：T869C与接受根治性放疗的非小细胞肺癌患者发生放射性肺炎的风险相关。
J Clin Oncol. 2009 Jul 10;27(20):3370-8. doi: 10.1200/JCO.2008.20.6763. Epub 2009 Apr 20.
2
Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan.放射治疗期间血浆转化生长因子-β1升高可预测非小细胞肺癌患者的放射性肺损伤：来自北京和密歇根的联合分析
Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1385-90. doi: 10.1016/j.ijrobp.2008.10.065. Epub 2009 Feb 21.
3
SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cells.SMAD6有助于非小细胞肺癌患者的生存，其敲低可重建肺癌细胞中的TGF-β稳态。
Cancer Res. 2008 Dec 1;68(23):9686-92. doi: 10.1158/0008-5472.CAN-08-1083.
4
Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies.AP 12009对复发性恶性胶质瘤中转化生长因子-β2的抑制作用：从临床前研究到I/II期研究
Oligonucleotides. 2007 Summer;17(2):201-12. doi: 10.1089/oli.2006.0053.
5
Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis.Smad7在人黑色素瘤细胞中的稳定过表达会损害骨转移。
Cancer Res. 2007 Mar 1;67(5):2317-24. doi: 10.1158/0008-5472.CAN-06-3950.
6
Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.Smad7表达对小鼠乳腺癌JygMC(A)细胞转移的影响。
J Natl Cancer Inst. 2005 Dec 7;97(23):1734-46. doi: 10.1093/jnci/dji399.
7
Non-Smad TGF-beta signals.非Smad转化生长因子-β信号
J Cell Sci. 2005 Aug 15;118(Pt 16):3573-84. doi: 10.1242/jcs.02554.
8
Selective inhibitors of type I receptor kinase block cellular transforming growth factor-beta signaling.I型受体激酶的选择性抑制剂可阻断细胞转化生长因子-β信号传导。
Biochem Pharmacol. 2004 Jul 1;68(1):41-50. doi: 10.1016/j.bcp.2004.03.011.
9
SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.SB-505124是转化生长因子-β I型受体ALK4、ALK5和ALK7的选择性抑制剂。
Mol Pharmacol. 2004 Mar;65(3):744-52. doi: 10.1124/mol.65.3.744.
Zotero 插件